ic 261 has been researched along with Liver Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fang, T; Guo, M; Huang, P; Li, D; Qi, F; Rao, Q; Sun, J; Xia, J; Yang, B; Yuan, F; Zhao, Z | 1 |
Andrysík, Z; Kabátková, M; Kohoutek, J; Kozubík, A; Machala, M; Procházková, J; Simečková, P; Umannová, L; Vondráček, J | 1 |
2 other study(ies) available for ic 261 and Liver Neoplasms
Article | Year |
---|---|
IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner.
Topics: Animals; Carcinoma, Hepatocellular; Casein Kinase 1 epsilon; Casein Kinase Idelta; Cell Line, Tumor; Cell Proliferation; Disease Progression; Humans; Indoles; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Phloroglucinol; Protein Kinase Inhibitors | 2020 |
Aryl hydrocarbon receptor-mediated disruption of contact inhibition is associated with connexin43 downregulation and inhibition of gap junctional intercellular communication.
Topics: Animals; Benz(a)Anthracenes; Carcinogens; Cell Communication; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Connexin 43; Contact Inhibition; Dose-Response Relationship, Drug; Down-Regulation; Epithelial Cells; Fluorenes; Gap Junctions; Gene Knockdown Techniques; Indoles; Ligands; Liver; Liver Neoplasms; Phloroglucinol; Phosphorylation; Polychlorinated Dibenzodioxins; Proteasome Endopeptidase Complex; Rats; Receptors, Aryl Hydrocarbon; RNA Interference; Signal Transduction; Time Factors; Transfection | 2013 |